Oesophageal sclerotherapy is now accepted as a successful treatment for bleeding varices. 1 The relative efficacy and safety of sclerosant injected intravenously or paravenously, however, has not been established and nor is it known why the number of treatments required for variceal obliteration varies from patient to patient. We have examined these factors and report our results here.
Methods

PATIENTS
Forty patients, aged 17-77 years, have been treated by injection sclerotherapy after a bleed from oesophageal varices. Twenty three were men and 17 women. Cirrhosis was present in 34; 17 alcoholic, eight primary biliary cirrhosis, six cryptogenic, two chronic active hepatitis, and one secondary biliary. The remainder had presinusoidal portal hypertension. All alcoholics abstained during the period of the study. The recorded on a clockface system, and the size of each variceal column was assessed by a subjective grading from 1 to 4, corresp onding with that recently described by Paquet. The sums of the variceal grades 1 cm and 5 cm above the gastro-oesophageal junction constituted a variceal score. Adequate grading was not possible in five patients and two had been injected once in another hospital.
Injections were generally performed at weekly intervals until the varices were thrombosed or markedly reduced in size. Thereafter treatment took place monthly until varices had disappeared.
Eight of the 40 patients took part in a radiologically controlled study to determine the effect of the site of injection. Two millilitres of a 1:3 mixture of 76% Urografin and 3% sodium tetradecyl sulphate were injected either intravenously or paravenously under radiological screening into two groups of 10 varices which were matched for size. Size and thrombosis of varices were assessed four weeks later without intervening injection. Thrombosis was determined by inspection of the varix for emptying and filling on respiration and straining, and by lateral pressure on the varix with the needle sheath. A patent varix will indent and the sheath can be drawn smoothly across, but a thrombosed varix offers resistance, will not indent and the flexible needle sheath itself bends.
Using the same radiological technique further studies were performed to assess how frequently an intended intravariceal injection was in fact paravariceal.
Results
Sclerotherapy alone was successful in 30 patients. Two further patients bled severely early in treatment and required oesophageal transection with a stapling gun5 before successful variceal elimination. The remaining eight patients died before therapy could be completed, five from hepatic failure, two from hepatic malignancy, and only one from bleeding varices. Further uncontrollable bleeding necessitated oesophageal transection in two of these before death. Minor bleeding occurred during treatment in a further 16 patients. This rebleeding occurred early in treatm nt in all but two patients, while the varices were st ge (Grade 3 or 4). There was no relationship betwe Child's grade and the initial variceal score nor with the success of treatment, although the incidence of rebleeding was higher in Child's grade C (Table) .
Patients with multiple large varices (Grades 3-4) required more injections to achieve obliteration than those with small varices (Grades 1 and 2) (Fig.  1) , the number of injections correlating with the variceal score (r=0.587, p<0.001). No patient with small varices only bled from them during treatment, except for one with a sclerosant related ulcer. In comparison, 10 out of 13 patients who had three or more large varices rebled. The difference between the numbers of large varices in the rebleeding and non-rebleeding groups is significant (p<0.01 MannWhitney U Test) (Fig. 2) .
RADIOLOGICAL STUDIES
When contrast was injected with the sclerosant into a varix it was rapidly cleared upwards in the direction of blood flow. Of 59 intended intravariceal injections whose site could be accurately identified Rose, Crane, and Smith Twenty varices were injected once with the sclerosant-contrast mixture, 10 intravenously and 10 paravenously (Fig. 3) . Intravariceal injection thrombosed eight out of 10 varices and gave rise to no complications; paravasal injection did not reduce variceal size, thrombosed only three out of 10 varices and was significantly less successful (p<0.05). One iatrogenic ulcer, which bled, was produced by paravasal injection and another patient complained of dysphagia for some weeks.
Discussion
Variceal size, and not portal pressure, determines the risk of bleeding6 and patients of Child's grade C rebleed more frequently.1 This study confirms also that patients with poor liver function have an increased chance of rebleeding during sclerotherapy and that the number of large varices also increases the risk of rebleeding, but neither factor alters the success of the treatment.
The assessment of both variceal size and thrombosis in this study was subjective but ftrading of size compares well with that of Paquet and a recent visit by one of us has confirmed this comparability. Large varices required more injections than small ones for obliteration, and proven intravariceal injection was very effective even when the varix was large. Our studies suggest that one in five injections into a large varix is paravasal and one in three for small varices. As it is impossible to aspirate blood up the injection needle into the syringe at the time of treatment, the endoscopist cannot check that the needle is in the vein, so the chance of extravascular injection of sclerosant increases as the vein becomes smaller. A proportion of injections are, therefore, less effective because the sclerosant is not intravenous, although paravasal injection may thrombose some small varices. The relationship between variceal obliteration and the development of an oesophageal stricture is probably a feature of multiple injections, some of which extravasate and produce submucosal fibrosis.7 Barsoum et als found submucosal extravasation during intravariceal injection in three out of six patients in the only other radiologically controlled study published. They used a rigid endoscope, with a rigid needle and injected 10 ml of sclerosant per varix, however, which may account for the high incidence of extravasation.
In previously reported series' 9 27% of patients developed oesophageal ulcers, and the pattern of paravasal injection suggests that this results from sclerosant spreading along the vein sheath, ulcerating the overlying mucosa. Occasionally the ulceration may even penetrate the vein wall to produce haemorrhage.
Injection of sclerosant in volumes and concentrations also used for intravariceal injection appears both ineffective and potentially dangerous. This is to be distinguished from 'Osophaguswandsklerosierung' -oesophageal wall sclerosis -pioneered by Wodak10 and practised by Paquet. 1 
